Objective: Attention-deficit/hyperactivity disorder (ADHD) is a common and highly heritable psychiatric condition. By exploiting the reported relationship between ADHD and educational attainment (EA), we here aimed to improve discovery of ADHD-associated genetic variants and investigate genetic overlap between these phenotypes.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition, caused by interplay of genetic and environmental risk factors. Its prevalence is estimated to be 5% in schoolaged children and 2.50% in adults 1 . The heritability of ADHD is one of the highest reported among psychiatric disorders in epidemiological studies, estimated at 0.70 0.80 1 . However, it has been difficult to identify genetic risk variants that account for the high heritability of ADHD, resulting in a relatively modest SNP-based heritability, currently estimated at 0.28 2 . This may be in part explained by its complex phenotypic structure (heterogeneous clinical features, developmental course and outcome, high rate of comorbid symptoms and disorders 3 ) and genetic architecture with a highly polygenic etiology, with both common and rare variants contributing small effects 4 . Moreover, large sample sizes are needed for reliable detection of such effects. The relatively small samples of existing ADHD genetic studies, as compared to those available for other psychiatric disorders 5, 6 , present an additional challenge. Up to now, no published GWASs have been able to detect genome-wide significant association ( ) for ADHD.
It is well-established that complex traits often have a polygenic structure with shared genetic background 7, 8 . Recently, a conditional/conjunctional false discovery rate (condFDR/conjFDR) method was developed 9 to exploit overlapping association across GWASs and thereby boost association signals in GWAS of one phenotype by combining it with genome-wide association data of another phenotype (condFDR) or enable detection of specific genetic loci shared between two phenotypes (conjFDR). If genetic overlap between two phenotypes exists, the method offers for increased statistical power compared to conventional multiple hypotheses testing approaches 10, 11 . This method was successfully applied to discover novel associations and to detect shared genetic variants in various complex disorders, including neurological 12, 13 and psychiatric 9 diseases.
ADHD is consistently associated with lower levels of EA 1, 14 : the percentage of US adolescents not completing high school is 5%, whereas it is approximately 35% for adolescents diagnosed with ADHD 15 . There are several ways in which ADHD may relate to lower EA, which are not mutually exclusive. First, the clinical and cognitive symptoms of ADHD (e.g. attention deficits) may directly perturb EA. Secondly, ADHD has a number of common comorbidities, including learning disabilities 16 , mood disorders 16 and disruptive behavior 16 , associated with lower EA. Another possibility is that ADHD and EA share causative factors. Recent findings demonstrate negative genetic correlation between ADHD and EA ( , , ) 17 , suggesting that genetic variants conferring risk to ADHD may contribute to lower EA in the general population. Thus, we can hypothesize that ADHD and EA may have a shared genetic basis and may amplify association signal by combining these phenotypes in condFDR/conjFDR method.
In contrast to ADHD, where the currently published largest GWASs contain less than 4000 cases 18, 19 , the latest GWAS on EA contains more than 300000 individuals, uncovering multiple genome-wide significantly associated loci 20 . Combining this EA GWAS with moderately-powered GWAS of ADHD 18 in the condFDR/conjFDR approach, we aimed here at identifying novel loci associated with ADHD as well as loci shared between ADHD and EA. The latter may provide insights into the molecular genetic mechanisms jointly influencing ADHD and EA and inform their biological underpinnings. Applying novel statistical methods, we also tested whether the observed phenotypic correlation between ADHD and EA implies a genetic correlation between these traits. Additionally, for the identified ADHD-associated variants, we assessed consistency of effect directions in an independent population based study of ADHD symptoms and performed in silico analyses of their functional effects (eQTL, expression quantitative loci).
Material and methods

Participant samples
We used ADHD data from the Psychiatric Genomics Consortium (PGC) 18 . The data set contains information from 2064 trios, 896 cases and 2455 controls. EA data were obtained from the Social Science Genetic Association Consortium (SSGAC) 20 , where EA was measured as the number of years of schooling completed that was harmonized between different educational systems. For our analyses, we used summary statistics generated by the meta-analysis of all discovery and replication cohorts, except the 23andMe sample (64 datasets with total ).
Top association signals identified in our analyses were examined in the summary statistics from an independent GWAS of ADHD symptoms performed by EArly Genetics and Lifecourse Epidemiology (EAGLE) consortium 21 . Unlike the PGC case-control ADHD GWAS, EAGLE GWAS represents a meta-analysis of 9 population-based pediatric cohorts containing information on 17666 children under the age of 13 years with measures of ADHD symptom scores.
Detailed description of data used for analysis and data preprocessing steps is given in the supplemental material available online.
Statistical analyses
To assess genetic overlap between ADHD and EA and thus warrant subsequent condFDR/conjFDR analysis, we generated conditional QQ plots and fold-enrichment plots in both directions: conditioning ADHD on EA and vice versa 9 . To explore the nature of the polygenic overlap and test the hypothesis that the investigated phenotypes correlate genetically, we calculated Pearson correlations between association z-scores of ADHD and EA SNPs within nested subset (strata) of SNPs with increasing 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 significance of p-values in either ADHD or EA (formal definition of SNP stratum is given in supplementary material, available online). To further support this hypothesis, we estimated genetic correlation between ADHD and EA using LD score regression 8 . Details of these analyses are described in supplementary material.
To identify specific loci associated with ADHD, we applied the condFDR method described previously 9 . The condFDR method takes summary statistics that reflect genetic association of a phenotype of interest (primary) together with those of an auxiliary (conditional) phenotype and estimates a posterior probability that a SNP is null (has no association) in the primary phenotype, given that p-values of the SNP in both the primary and conditional phenotypes are lower than observed p-values. Thus, the condFDR method increases the power to discover loci associated with a primary phenotype by leveraging associations with a secondary phenotype. It does so by re-ranking SNPs compared to nominal p-value-based ranking 9 . In contrast, ranking SNPs based on unconditional FDR (e.g. using Benjamini Hochberg or Benjamini Yekutieli procedure) does not change their order (compared to nominal p-values).
Although both conditional QQ plots and genetic correlation based on the LD score regression can be useful to get a general idea of whether two traits have a significant genetic overlap, they are unable to find specific susceptibility loci shared by the traits. The conjFDR approach is an extension of condFDR allowing the identification of specific loci associated with both traits 9 . The conjFDR is defined as the maximum of the two condFDR values (taking one phenotype as primary and another as conditional and vice versa) for a specific SNP. Thus, the conjFDR approach estimates a posterior probability that an SNP is null for either phenotype or both at the same time, given that the p-values for both phenotypes are lower than the observed p-values. The method, therefore, uncovers loci associated with both phenotypes simultaneously. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 To avoid inflation of the results due to LD-dependency in fold-enrichment and QQ plots as well as in condFDR/conjFDR analyses, we randomly pruned all SNPs across 500 iterations. For each iteration, all but one random SNP in each LD-independent region (clump of SNPs in strong LD, ) were removed, and finally the results were averaged across all iterations. LD (r 2 values) was estimated based on the 1000 Genomes Project phase 3 European sub-population data using PLINK 22 .
As for meta-analyses based on multiple data-sources, the quality of our condFDR/conjFDR analysis will depend on the robustness of the primary data. More details about condFDR and conjFDR methods can be found in supplementary material and in the original publication 9 .
Evaluation of the detected ADHD loci in an independent study of ADHD symptoms
We used genetic data on association of ADHD symptoms obtained from EAGLE consortium to test whether our results can be supported by data from the independent sample. For this purpose, we checked whether effects of the most significant SNPs in the loci identified by condFDR/conjFDR analyses are consistent between PGC ADHD and EAGLE data sets.
In silico identification of allele-specific effects of significant SNPs on transcription
Identifying and investigating genetic variants that might affect gene expression (expression quantitative trait loci or eQTLs) may shed light on how associated variants may contribute to biological mechanisms underlying a phenotype. eQTLs vary significantly both between different tissues and over time 23 . Existing GWASs on ADHD and EA clearly demonstrate remarkable enrichment of association signals in genomic regions implicated in regulation of gene expression in brain 18, 20 . Hence, we focused on eQTL analysis of genes expressed in brain tissues. Significant associations identified with condFDR and conjFDR analyses were queried for known eQTLs using the GTEx portal (http://gtexportal.org) and the Braineac database (http://www.braineac.org). The latter database contains information on cis-eQTLs for 10 brain regions: cerebellar cortex, frontal 
Results
Evaluation of genetic overlap and correlation
In the absence of genetic overlap between two traits, it is expected that p-values for association with one trait are independent from the p-values for association with the other. However, conditional QQ plots in Figure 1 clearly demonstrate an increasing degree of leftward deflection for strata of more significant SNPs. This is observed both when conditioning ADHD on EA ( Figure 1A ) and vice versa ( Figure 1B ), suggesting substantial cross-trait polygenic enrichment. Enrichment of association signals for one trait among those of another is also clearly visible in the fold-enrichment plots, with more than 10-fold enrichment of SNPs from the strictest stratum ( ) for both traits ( Figure S1 , available online). Additionally, association z-scores of ADHD and EA demonstrate increasing negative correlation in more strictly defined strata of SNPs, both when strata are defined based on ADHD p-values ( Figure 1C ) and on EA p-values ( Figure 1D ). Moreover, LD score regression analysis also showed significant negative genetic correlation ( , , ) between these phenotypes.
Identification of ADHD-associated loci and loci shared between ADHD and EA
Using the condFDR/conjFDR method we identified 5 LD-independent regions, significantly associated with ADHD ( , ), 3 of which were also identified as shared between ADHD and EA. From each of these regions a single SNP with the lowest condFDR/conjFDR value (strongest association signal) was selected to represent their loci. These SNPs are presented in Table 1 . Manhattan plots resulting from condFDR and conjFDR analyses are presented in Figures 2 and 3 , respectively. Four out of five identified most significant SNPs revealed the opposite directions of effect in ADHD and EA.
Identified loci and related genes
Two loci (represented in Table 1 by variants rs618678 and rs412458) were identified both in condFDR and conjFDR analyses. rs618678 represents the strongest signal in the conjFDR analysis ( ) and the second strongest in the condFDR analysis ( ). This SNP is an intronic variant within KDM4A on chromosome 1p34.2 ( Figure 4B ). Figure 4B and Figure   S2B (available online) show the genetic context of rs618678, indicating, respectively, the conjFDR and condFDR values of adjacent SNPs. It is worth noting that in our analysis rs618678 tags a broad region of association. As can be seen in Figure 4B , multiple significant SNPs in strong LD ( ) with rs618678 were detected in this region, spanning over more than 200000 basepairs (bp).
Besides KDM4A, the region also contains PTPRF (located in 1p34.2, upstream of KDM4A) and ST3GAL3 (1p34.1, directly downstream KDM4A) genes. The latter was also identified in the eQTL analysis (discussed below). Another significant signal identified in both condFDR ( ) and conjFDR ( ) analyses is represented by rs412458, an intronic variant within MEF2C on chromosome 5q14.3 ( Figure S2A , D, available online).
Two loci were identified by condFDR, but not conjFDR. The strongest signal was detected at rs4324303 ( ), that is in the intergenic region on chromosome 2p24 ( Figure   4A ). Multiple significant variants tagged by rs4477079 ( ) were also identified on chromosome 8 within RUNX1T1 ( Figure S2C , available online). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Finally, conjFDR analysis identified a shared variant ( ) at PINK1 (rs17414302, intronic, 1p36.12) ( Figure S2E , available online). There were no LD-linked SNPs in the direct vicinity and only 25 SNPs in LD ( ) with this variant, residing upstream of PINK1, at about 100000 bp.
None of SNPs identified either in condFDR or conjFDR reached genome-wide significance in previously published GWAS of ADHD 18 . Rs618678 reached genome-wide significance in EA ( ) 20 . Rs412458, which was identified by both condFDR and conjFDR, was not reported as genome-wide significant by the published EA GWAS ( ), but it is in LD ( ) with rs588282 that did reach genome-wide significance in that study (previously reported ). Other loci identified in our analyses were below genome-wide significance threshold in EA. It is also worth noting that the unconditional FDR values for all identified SNPs were above 0.01 and 0.05 in condFDR and conjFDR analysis respectively.
Evaluation of the detected ADHD loci in an independent study of ADHD symptoms
To assess the robustness of our results, we examined the loci identified in either the condFDR or conjFDR analyses (Table 1) in the association summary statistics from the independent GWAS of ADHD symptoms conducted by EAGLE consortium 21 . Four out of five loci (represented by SNPs:
rs17414302, rs412458, rs618678, rs4324303) have the same direction of effect in the PGC and EAGLE GWASs while the last locus (represented by rs4477079 SNP) has an opposite direction of effect in these GWASs. These results are presented in Table S2 (available online).
In silico identification of allele-specific effects on transcription
According to Human Brain Transcriptome data 24 , all six implicated genes (Table 1 , Genes in the region) have a pronounced expression in different brain regions during the whole life cycle (Figure   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 S3, available online). Therefore, alterations in the expression level of these genes (where the detected SNPs are located) may affect a broad variety of processes over an extended period. We scanned the Braineac database to check whether SNPs identified in either the condFDR or conjFDR analyses are associated with gene expression in brain tissues. We found that four of five SNPs from Table 1 may operate as eQTLs, significantly ( ) associated with the expression of 13 different genes in several brain regions (Table S1 , available online). Among those 13 genes, the most significant eQTL was observed between rs618678 and ST3GAL3. Further, significant eQTL effects of rs618678 on ST3GAL3 were identified in muscle-skeletal tissue ( ) in the GTEx database (https://gtexportal.org/), but not in the brain tissue.
Discussion
The present study sought to investigate the genetic overlap between ADHD and EA, to leverage their potentially common genetics in order to improve the discovery of ADHD-associated loci and help our understanding of the correlation between EA and ADHD observed in epidemiological studies. It is, however, worth emphasizing the broad potential of the applied methodology, which can be used to leverage the great variety of existing GWAS data for dissecting the molecular genetic basis underlying complex human traits and disorders and their shared genetic etiology.
We identified significant genetic overlap between ADHD and EA supported by a pronounced genetic correlation ( , , ), consistent enrichment of shared variants in conditional QQ plots ( Figure 1A , B), more than 10-fold mutual enrichment of SNPs associated with both traits ( Figure S1 , available online) and growing negative correlation of association z-scores for the nested SNP strata with increasing significance in both traits ( Figure 1C , D). These findings 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 encourage the hypothesis that there is a shared genetic basis underlying ADHD and EA where in general ADHD risk alleles are associated with lower EA.
In comparison to previous study, exploring the topic of genetic overlap between ADHD and EA 17 , our analysis employs a much larger data set of EA, allowing for a more reliable detection of genetic overlap (Figure 1 ; , , ). It is also worth noting that we report a genetic correlation that is stronger than previously observed using the same ADHD data and a smaller ( ) EA dataset ( , , ) 17 . Moreover, our study provides further insights into the shared genetic basis of ADHD and EA by identifying specific genetic loci jointly influencing these phenotypes. Further studies are warranted to determine in what way these genetic variants influence ADHD and EA. It is feasible that the shared genetic effects may influence EA through an intermediary phenotype such as reading disability, which is comorbid to ADHD 25 , or through more basic neurobiological systems.
By combining GWAS summary statistics data on ADHD and EA 18, 20 in the condFDR/conjFDR analyses, we enhanced discovery in the moderately powered ADHD GWAS and found five novel LDindependent loci associated with ADHD (Table 1) . None of the loci identified in our analyses reached genome-wide significance in the ADHD GWAS 18 , while rs618678 and rs412458 reached genomewide significance in the GWAS of EA 20 . Four of five loci have opposite directions of effect in PGC case-control ADHD study 18 and EA study 20 (Table 1) and consistent directions of effect in the independent population-based study of ADHD symptoms from the EAGLE consortium 21 (Table S2, available online). The only SNP (rs4477079) having the same direction of effect in PGC ADHD data set and EA also has inconsistent effect directions in the PGC ADHD and EAGLE ADHD datasets.
Despite the relatively small GWAS sample sizes on ADHD by the PGC 18 and EAGLE 21 consortia, and their differences in definitions of phenotype, observed consistency of effect directions of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 identified variants supports the credibility of the findings and the statistical approach. The fact that the majority of identified SNPs had opposite directions of effect in ADHD and EA is in line with the observed negative genetic correlation and corresponds to the expectations that can be drawn from existing clinical studies demonstrating poor academic performance and decreased rates of high school graduation and postsecondary education in individuals with diagnosed ADHD 14 . Altogether, these findings provide new insights into the genetic architecture of ADHD, suggesting shared molecular genetic mechanisms with EA. Furthermore, the findings may suggest that individuals with a high load of ADHD genetic risk factors, but not necessarily with the disorder itself, may be at higher risk for lower EA.
The most significant locus shared between ADHD and EA (rs618678) is located on chromosome 1 and represents a broad region of association spanning over more than 200,000 bp in 1p34.2 and 1p34.1 ( Figure 4B ; Figure S2B , available online). This region contains three protein coding genes: PTPRF, KDM4A and ST3GAL3. rs618678 is an intronic variant within KDM4A, a member of the Jumonji domain 2 family, which encodes a protein that demethylates histone residues, and acts as an epigenetic transcriptional regulator 26 . Genome-wide significant variants within KDM4A were reported in a recent GWAS of schizophrenia 5 , a disorder that may share genetic background with ADHD. The protein encoded by PTPRF is a member of the protein tyrosine phosphatase (PTP) family, which regulates a variety of cellular processes, including cell growth, differentiation, mitotic cycle and oncogenic transformation. Mouse studies showed that PTPRF promotes neurogenesis in the hippocampus 27 , a brain region linked to memory. ST3GAL3 encodes a sialyltransferase responsible for the terminal sialylation of brain gangliosides and glycoproteins, which constitute a major part of the surface glycan coat of neurons and glia and act as an interface for cellular interactions 28 . Interestingly, mutations of ST3GAL3 may impair the development of higher cognitive functions 29 and are associated with severe infantile epilepsy 30 . Our eQTL analysis with Braineac database revealed strong associations of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 rs618678 with altered expression of ST3GAL3 (Table S1 , available online), suggesting that this may be a potential mechanism whereby this locus affects ADHD and EA. However, this association was not detected using GTEx database. The discrepancy between the results from the different eQTLdatasets could be attributed to differences in methodological techniques or sample configuration between the eQTL databases, or reflect the relatively small sample sizes. The eQTL results should be re-assessed when larger brain-eQTL databases are available.
The second locus shared between ADHD and EA (rs412458) is an intronic variant within MEF2C
( Figure S2A 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 represents an isolated signal with rather poor LD support ( Figure S2E , available online) and it should thus be examined in more detail.
The strongest SNP association with ADHD revealed by the condFDR analysis was rs4324303. This SNP was not significant in the conjFDR analysis, but showed consistent direction of effect with ADHD symptoms in the EAGLE sample, possibly suggesting a putative role specific to ADHD.
Rs4324303 is an intergenic variant located approximately 1 mega base upstream of the nearest protein coding gene (TRIB2). It is therefore difficult to speculate about the potential role of this variant in different cellular processes.
Another variant identified by the condFDR analysis is rs4477079, an intronic variant within RUNX1T1 (Table S2 ) and a co-directional effect between PGC ADHD risk and EA (Table 1) . The latter is contrary to expectations based on previous findings. The role of RUNX1T, thus, remains puzzling and further studies are needed to clarify it.
To further evaluate the ADHD-associated variants identified in this study utilizing the data from PGC 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 evidence that the diagnosis of ADHD can be considered as the extreme of a continuous trait 45 and several studies show that the polygenic risk score computed from an association study of ADHD diagnosis predicts the variability of ADHD symptoms in population samples 21, 46 . Additionally, it has been shown that the continuous measure of ADHD (such as symptom score) and the ADHD diagnosis share over 90% of their genetic background 47 . Thus, the results of the performed exploration may be viewed as confirmatory of our findings.
It is also worth mentioning that two loci identified in our analyses (corresponding to rs618678 and rs412458 in Table 1 ) were reported to reach genome-wide significance in the largest GWAS on ADHD performed to date, with the total number of 20183 ADHD cases and 35191 controls. In this GWAS, ADHD diagnosis was based on either ICD10 or DSM-IV. The study is yet unpublished but preprint is available in bioRxiv 47 .
As children with ADHD have been reported to have high risk for academic failure, school dropout, grade repetition and placement in special education 48,49 , it is likely that the prevalence of ADHD cases among individuals with lower EA would be increased compared to the prevalence among individuals with higher EA. Moreover, ADHD is known to have a complex pattern of co-morbid conditions 1 (including dyslexia 25 , oppositional defiant disorder 50 and others), many of them are also associated with lower EA. This potential overlap of phenotypes prevents us from translating the genetic correlation into actual pleiotropy, which is defined as the same gene variant affecting independent diseases or traits. Furthermore, it is challenging to evaluate small effect sizes, and speculate about molecular mechanisms behind the effective variants when examining such potentially overlapping phenotypes. Another general problem is that the effects of the associated variants are small and their functional roles have not been directly investigated. Associated genetic loci contain several genes and it is difficult to establish an arrow of causality when studying association between traits. Thus, the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 question whether ADHD is diagnosed because of observed educational problems or ADHD is the cause of subsequent educational problems or there is other common underlying factor needs further exploration.
Also of possible relevance is the sample overlap between PGC ADHD and EA datasets (both GWASs include the WTCCC58C cohort 51 ), which may inflate the results of our FDR analyses. However, the results of LD score regression, which are in line with those of our FDR analyses, are not affected by the sample overlap 8 .
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Participant samples
We used ADHD data from the Psychiatric Genomics Consortium (PGC) 1 . The data set contains information from 2064 trios, 896 cases and 2455 controls combined from four independent studies (CHOP 2 , IMAGE 3 , IMAGE II 4 , PUWMa 5 ). Each dataset has undergone stringent quality control (including filtering out SNPs with high missingness and significant deviation from Hardy-Weinberg equilibrium) and was imputed using HapMap Phase III European CEU and TSI samples as the reference panels. The association analysis was performed separately on each dataset and the inverse variance weight meta-analysis has been carried out. Details of the data processing steps and the analyses are described in the original publication 1 . Prior to our analyses, we performed basic quality control of the obtained PGC summary statistics: SNPs with low imputation quality (info score < 0.80) and minor allele frequency (MAF) < 0.01 were excluded. Additionally, we removed the major histocompatibility complex (MHC) region (defined on hg19 as chr6: 28477797 -33448354). The remaining 6393963 SNPs were used for the analyses. For quantile-quantile (QQ) and enrichment plots as well as for conjFDR analyses, all p-values were adjusted by genomic control inflation factor as described previously 6, 7 .
Different ADHD diagnostic procedures were used across studies. Below we briefly summarize phenotype measurement procedures in each study (taken from the original publications).
CHOP: trio families were recruited from pediatric and behavioral health clinics in the Philadelphia area. Inclusion criteria included families of European descent with an ADHD proband (age 6 -18). Exclusion criteria included prematurity (< 36 weeks), mental retardation, major medical and neurological disorders, pervasive developmental disorder, psychoses and major mood disorders. A child psychiatrist assessed diagnostic status of ADHD probands by K-SADS P-IVR interview. Parental ADHD was assessed using the ADHD Self-Report Scale.
IMAGE: trio families of European origin were collected using a common protocol with centralized training and reliability testing of raters and centralized data management. Families were identified through ADHD probands aged 5 to 17 attending outpatient clinics at the data collection sites in Europe and Israel. Exclusion criteria were autism, epilepsy, IQ < 70, brain disorders and any genetic or medical disorder associated with externalizing behaviors that might mimic ADHD. Parents of children were interviewed with the Parental Account of Childhood Symptom (PACS), a semi-structured, standardized, investigator-based interview developed as an instrument to provide an objective measure of child behavior. Both parents and teachers completed the respective versions of the Conners ADHD rating scales and the Strengths and Difficulties Questionnaire. Using results of these surveys, probands had been clinically diagnosed as ADHD based on the DSM-IV criteria (or hyperkinetic disorder, the most closely equivalent category in the ICD-10 nomenclature used at some of the clinics).
IMAGE II: a case-control study using samples collected by the IMAGE project (but not included in the IMAGE GWAS) and samples collected at additional sites (Germany, Scotland and Cardiff, UK) that were assessed in a manner similar to IMAGE samples. Cases were identified mainly through outpatient clinics at the data collection sites.
PUWMa: trio families were collected independently at three sites (MGH, Washington University and UCLA) using similar but slightly different methods. Children were 5 -19 years of age at initial assessment and met criteria for DSM-IV-TR ADHD.
MGH. Psychiatric assessments were made with K-SADSE (Epidemiologic Version) interview (indirect interviews with parents and additionally direct interviews with subjects older than 12). Exclusion criteria included major sensorimotor handicaps (deafness, blindness), psychosis/schizophrenia, autism, inadequate command of the English language, or a Full Scale IQ less than 80.
Washington University. Parents reported on their children and themselves, and the youths on themselves, using the Missouri Assessment of Genetics Interview for Children (MAGIC), a semi-structured psychiatric interview. DSM-IV diagnoses of ADHD were based upon parental reports. Families were excluded if a parent/guardian reported mental retardation or if the parent/guardian and twins could not speak English.
UCLA. Lifetime psychiatric diagnoses were based on semi-structured diagnostic interviewers with extensive experience and reliability training in psychiatric diagnoses. Children and adolescents were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL). Adult parents were assessed using the Schedule for Affective Disorders and Schizophrenia-Lifetime version (SADS-LA-IV), supplemented with the K-SADS Behavioral Disorders module for diagnosis of ADHD. Direct interviews were supplemented with parent and teacher versions of the Swanson, Nolan, and Pelham, version IV (SNAP-IV) rating scale, as well as a parent-completed CBCL and Teacher Report Form. Parents also completed current ratings of self and spouse behavior with the ADHD Rating Scale IV. Best estimate diagnoses were assigned using all of the available clinical information according to strict DSM-IV criteria and reviewed by senior clinicians. Subjects were excluded from participation if they were positive for any of the following: neurological disorder, head injury resulting in concussion, lifetime diagnoses of schizophrenia or autism, or estimated Full Scale IQ < 70.
EA data were obtained from the Social Science Genetic Association Consortium (SSGAC) 8 , where EA population under various educational systems, the International Standard Classification of Education (ISCED) of the United Nations Educational, Scientific and Cultural Organization (UNESCO) was used. Each major educational qualification that it is possible to attain in a specific country was mapped into one of seven ISCED categories. To construct the primary outcome variable, each ISCED category was then translated into US years of schooling. So eventually educational attainment for all subjects in the study (regardless of country of birth) was measured in US years of schooling.. For our analyses, we used summary statistics generated by the metaanalysis of all discovery and replication cohorts, except the 23andMe sample which is not publicly available (64 datasets with total N = 328917). For each dataset, genome-wide association was tested using only individuals of European descent, with EA assessed at age 30 or above. Cohortlevel data underwent various quality control procedures (filtering out SNPs with high missingness and significant deviation from Hardy-Weinberg equilibrium etc.) and a round of genomic control. Sample-size-weighted meta-analysis of all 9256490 autosomal SNPs (from the 1000 Genomes Project) passing quality control procedures was performed using METAL 9 . Detailed information on sample selection, cohort-level quality control and meta-analysis can be found in the original publication 8 . Before conducting our analyses, we removed MHC region. In addition, for QQ plots, enrichment plots and conjFDR analyses, we also corrected p-values for genomic inflation (as defined above). The data are available for downloading at (http://www.thessgac.org/data).
We examined our top association signals in the summary statistics from an independent GWAS of ADHD symptoms performed by EArly Genetics and Lifecourse Epidemiology (EAGLE) consortium 10 . Unlike the PGC case-control ADHD GWAS, EAGLE GWAS represents a metaanalysis of 9 population-based pediatric cohorts containing information on 17666 children under the age of 13 years with measures of ADHD symptom scores. Several different measures of ADHD symptom scores were used across cohorts, including the Attention Problems scale of the Child Behavior Checklist (CBCL) and the Teacher Report Form (TRF), the Hyperactivity scale of the Strengths and Difficulties Questionnaire (SDQ) and the DSM-IV ADHD items (e.g. as included in Rating Scale) [11] [12] [13] [14] [15] . For the meta-analysis, one phenotype was selected from each cohort. Based on the phenotype that was most available, school-age ratings were chosen over preschool-age ratings, parent ratings over teacher ratings, and the measurement instrument with -IV > CBCL > SDQ). The study did not detect genome-wide significant SNPs.
LD score regression
To support a hypothesis of shared genetic basis between ADHD and EA we applied linkage disequilibrium (LD) score regression 16 to estimate SNP-based genetic correlation between them. For this calculation, we used only SNPs overlapping with HapMap phase 3 variants, while low quality imputed markers as well as indels, rare variants (MAF < 0.01) and markers from the MHC region were removed from both data sets as described in the main text. The analysis was performed using the Python-based package available at (https://github.com/bulik/ldsc) and the procedure is described in the documentation of the package (https://github.com/bulik/ldsc/wiki/Heritabilityand-Genetic-Correlation). Since we know that there is sample overlap between ADHD and EA pt. Obtained genetic correlation was significantly below zero (rg = -0.403, SE = 0.075). Similar values can be obtained using LD Hub (http://ldsc.broadinstitute.org) available at LD Hub. The obtained genetic correlation is in line with our findings obtained with conjFDR model, where all three markers are significantly associated with both ADHD and EA presenting opposite directions of effect (Table 1) . It is worth noting here that LD score based genetic correlation allows effective detection of genetic correlation only when the bulk of variants associated with both traits reveals strong net correlation between the direction of effects of overlapping SNPs relative to each other (i.e. correlated same or opposite direction of effects in two phenotypes, but not mixed). The method is also not able to identify specific shared loci. To circumvent the latter, we applied conjFDR method described below.
Fold enrichment plot
The fold enrichment plot allows the assessment of genetic enrichment in one (primary) trait when conditioning on another (conditional) trait. Enrichment is present if the degree of upward deflection from the expected null level (horizontal line through 1) depends on the stratum defined by the p-values for association with the trait used for conditioning (e.g. pconditinal trait < 1.00x10 -1 ).
Here by SNP stratum corresponding to some p-value threshold pthresh in trait T (either ADHD or EA) we mean a set of SNPs for which z-scores are available in both ADHD and EA GWASs and which have p-values in trait T below the threshold pthresh.
First, the empirical cumulative distribution function (CDF) of primary trait association p-values is computed for all SNPs. Then the CDF of association p-values is also estimated for each SNP stratum defined by the p-values for association with the conditional trait. Then fold enrichment for each stratum is estimated as the ratio CDFstratum/CDFall. The x-axis displays nominal -log10(pvalue) for the primary trait, the y-axis shows the fold enrichment. Here we focus on polygenic effects for SNPs not reaching the standard GWAS significance threshold -log10(p) < 7.30 (corresponding to p > 5.00 -8 ). Figure S1 . Fold enrichment of association between ADHD and educational attainment (EA). Fold enrichment plots of the observed -log10 -8 ) in the primary trait stratified based on the association with the conditional trait. A sequence of four nested strata is presented: all SNPs (i.e. p-values of the conditional trait <= 1), pconditinal trait < 10 -1 , pconditinoal trait < 10 -2 and pconditinoal trait < 10 -3 . Successive upward elevation compared to all SNPs demonstrates polygenic enrichment both for ADHD conditioned on educational attainment (A) and for educational attainment conditioned on ADHD (B).
Conditional/Conjunctional FDR
The following brief description of conditional/conjunctional false discovery rate (condFDR/conjFDR) method is based on the papers 6, 7 where the method was introduced and subsequent correction to the second paper 17 .
To explain the condFDR/conjFDR method, we will first review the concept of standard (unconditional) false discovery rate (FDR). Then we describe the condFDR method. The latter is an extension of the standard FDR, which incorporates information from genome-wide association summary statistics of a second phenotype to adjust its significance level. After that we will present a formal definition of conjFDR for two phenotypes and show that it can be estimated as a maximum of two conditional FDRs.
In empirical Bayes interpretation, for a given p-value cutoff, FDR can be defined as follows 18 :
where is the a priori fraction of null SNPs, is the null cumulative distribution function (CDF), and is the CDF of all SNPs, both null and non-null. Under the null hypothesis, is the CDF of the uniform distribution on the unit interval [0,1], so and the latter formula reduces to:
. Having this definition, the conditional FDR for two phenotypes can be defined as the posterior probability that a given SNP is null for the first phenotype given that the p-values for both phenotypes are as small as or smaller than the observed p-values. Formally this can be expressed as:
where and are p-values of SNPs in the first and the second phenotypes correspondingly, is the conditional proportion of null SNPs and is the conditional cdf for the first phenotype given that p-values for the second phenotype are or smaller. We denote the conditional FDR for phenotype 1 (pt1) given phenotype 2 (pt2) as . In our calculations, we produce a conservative estimate of by setting and using the empirical conditional cdf in place of .
In our study, conjFDR is used to identify SNPs that are associated with two phenotypes simultaneously. It is defined as the posterior probability that a given SNP is null for either phenotype or both phenotypes simultaneously when the p-values for both phenotypes are as small or smaller than the observed p-values. Formally, the conjunctional FDR is defined as:
where is the a priori fraction of SNPs null for both phenotypes simultaneously, is the joint null cdf, is the a priori fraction of SNPs non-null for the pt1 and null for pt2 with the joint cdf of these SNPs, and is the a priori proportion of SNPs non-null for pt2 and null for pt1, with joint cdf . is the joint overall mixture cdf for all SNPs of both phenotypes. We denote conjunctional FDR for phenotype 1 and phenotype 2 as .
A model-free conservative estimation of the conjunctional FDR for phenotypes pt1 and pt2 can be calculated as:
Using upwardly biased estimates of conditional FDRs and as described above and noting that for enriched samples, p-values will tend to be smaller than predicted from the uniform distribution (giving and ), the latter equation follows from:
Assuming that SNPs are independent if one or both are null (that is reasonable for disjoint samples), the last quantity is exactly equal to the formal definition of above.
Identified ADHD associated loci Figure S2 . Genetic surrounding of the SNPs identified in the condFDR (upper row, A, B, C) or in the conjFDR (lower row, D, E) analyses except the SNPs with the strongest associations from each analysis (presented in the main text). Values for both genotyped and imputed variants are shown on the left y-axis as log10(condFDR) and log10(conjFDR) respectively. In each subplot, the SNP with the strongest association is shown in the large purple t associated SNP measured as r 2 coefficient (described in the legend). The recombination rate is plotted as a blue solid line, its value in centimorgan/megabase (cM/Mb) is indicated on the right y-axis. Red dotted lines indicate the FDR significance threshold (0.01 for condFDR and 0.05 for conjFDR). Figures were generated with LocusZoom tool 19 available online: http://locuszoom.sph.umich.edu/locuszoom/ eQTL analyses Figure S3 . Temporal expression in brain regions for genes from 5 loci identified either in condFDR or in conjFDR analyses. Expression profiles are obtained from the Human Brain Transcriptome database (http://hbatlas.org). Gene expression along entire development and adulthood in the cerebellar cortex (CBC), mediodorsal nucleus of the thalamus (MD), striatum (STR), amygdala (AMY), hippocampus (HIP) and neocortex (NCX) is demonstrated. Table S1 . Genes with expression levels significantly associated with one of SNPs identified as significant either in condFDR or in conjFDR analyses (Table 1) according to Braineac database (http://www.braineac.org). First column (Gene) represents the gene symbol. Second column (SNP) shows the rs number of the SNP that affects gene expression. Third column (exprID) indicates the identification number of exon-specific probeset affected by the SNP n the exon level). Fourth column (aveALL) demonstrates p-value for average expression across all 10 brain tissues available in Braineac. The remaining 7 columns contain eQTL p-values for 7 different brain regions: HIPP (hippocampus), occipital OCTX (cortex, specifically primary visual cortex), PUTM (putamen), SNIG (substantia nigra), TCTX (temporal cortex), THAL (thalamus) and WHMT (intralobular white matter). Significant p-values (< 0.001) are highlighted in red. The remaining 3 brain regions available in Braineac: cerebellar cortex, frontal cortex and medulla (specifically inferior olivary nucleus) are not included in the table because none of the genes affected by identified SNPs have significantly altered expression level in these tissues. Table S2 . The most significant SNPs in the loci identified by condFDR/conjFDR, their effect sizes and association p-values in PGC ADHD GWAS and EAGLE GWAS of ADHD symptoms.
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